openPR Logo
Press release

Global Pentavalent Antimonials Market Size, Share, Analysis, Industry Report and Forecast 2021-2027

02-04-2022 12:19 PM CET | Health & Medicine

Press release from: Orion Market Research

The global pentavalent antimonials market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Pentavalent antimonials are a class of compounds used for the treatment of leishmaniasis. Antimonials have largely been used for the treatment of cutaneous and mucocutaneous leishmaniasis. These are widely available for use as an aqueous solution for intravenous or intramuscular use. Pentavalent antimonials are available as Sodium stibogluconate and meglumine antimoniate. Advances in existing anti-leishmanial drugs which further result in effective and safer formulations, have been witnessed as the latest market trend which is primarily driving the market growth. For instance, as per the data of the Drugs for Neglected Diseases initiative (DNDi), 2 new chemical entities labelled as DNDI-6148 and DNDI-0690 were introduced into the preclinical development stage for the treatment of visceral and cutaneous leishmaniasis in 2016.

To Request a Sample of our Report on Global Pentavalent Antimonials Market: https://www.omrglobal.com/request-sample/pentavalent-antimonials-market

Immunomodulator- CpG-D35, is also in a pre-clinical development stage, which is proposed to be used as an adjunct apart from the main drug therapy to treat cutaneous leishmaniasis. Such developments and advancements are anticipated to augment the global market growth. Additionally, several initiatives and government efforts have been witnessed to increase visceral leishmaniasis surveillance, diagnosis, vector control, as well as its treatment, which ultimately, is projected to positively impact the market growth. For instance, the World Health Organization (WHO) had launched an action plan for reducing the impact of Neglected Tropical Diseases (NTDs), including visceral leishmaniasis in 2012.

Some key players operating in the market include Sanofi S.A. and GlaxoSmithKline plc, among others. The market players are focusing on strengthening their position in the market by adopting various strategies such as mergers and acquisitions, partnerships, collaborations, new product launches and development in the existing product portfolio, and so on. For instance, in 2016, the WHO and Gilead Sciences, Inc. signed an agreement to donate 380,400 vials of AmBisome (liposomal amphotericin B), extending their previous agreement from 2016 to 2021. This five-year collaboration aided by the funding of $20 million by Gilead Sciences, Inc. is aimed to provide access to diagnosis and treatment to the populations affected by visceral leishmaniasis in key endemic countries, majorly India, Ethiopia, South Sudan, Nepal, Bangladesh, and Sudan.

Market Coverage

· The market number available for – 2020-2027

· Base year- 2020

· Forecast period- 2021-2027

· Segment Covered

· Regions Covered- Globally

· Competitive Landscape: Sanofi S.A. and GlaxoSmithKline plc, among others.

(Get 15% Discount on Buying this Report)

A full Report of Global Pentavalent Antimonials Market is Available at: https://www.omrglobal.com/industry-reports/pentavalent-antimonials-market

Global Pentavalent Antimonials Market Report by Segment

By Type

• Sodium Stibogluconate

• Meglumine Antimoniate

By Distribution Channel

• Hospital Pharmacies

• Retail Pharmacies

• Online Pharmacies

Global Pentavalent Antimonials Market by Region

North America

· United States

· Canada

Europe

· UK

· Germany

· Spain

· France

· Italy

· Rest of Europe

Asia-Pacific

· India

· China

· Japan

· South Korea

· Rest of APAC

Rest of the World

Reasons to buy from us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pentavalent Antimonials Market Size, Share, Analysis, Industry Report and Forecast 2021-2027 here

News-ID: 2545324 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Pentavalent

Pentavalent Vaccine Market: A Comprehensive Overview of the Industry's Players a …
► Global Pentavalent Vaccine Market size was valued at USD 2.73 Bn. in 2024 and the total Pentavalent Vaccine Market revenue is expected to grow by 3.3% from 2025 to 2032, reaching nearly USD 3.54 Bn. The pentavalent vaccine market is evolving as global healthcare systems increasingly prioritize comprehensive immunization programs to protect children from multiple infectious diseases with a single shot. This vaccine, which combines protection against diphtheria, tetanus, pertussis,
Fully Liquid Pentavalent Vaccine Market Outlook and Future Projections for 2030
The fully liquid pentavalent vaccine market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines
Key Trend Reshaping the Pentavalent Market in 2025: Key Companies Drive Growth T …
Which drivers are expected to have the greatest impact on the over the pentavalent market's growth? The steady increase in the occurrence of diphtheria is projected to foster the pentavalent market's expansion. Corynebacterium diphtheriae is a bacterial strain responsible for the highly communicable and severe disease known as diphtheria. This disease can cause serious issues with eating and breathing, and could potentially result in skin ulcers. The pentavalent vaccine offers protection
Fully Liquid Pentavalent Vaccine Market Outlook and Future Projections for 2030
The fully liquid pentavalent vaccine market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines
Pentavalent Market Size, Share, Growth Analysis, Forecast and Report 2024-2033
The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2033 The Business Research Company presents an extensive market research report on the Pentavalent Global Market Report 2024, furnishing businesses with a competitive edge through a detailed examination of the market structure, encompassing estimates for various segments and sub-segments. Furthermore, the report highlights on emerging trends, significant drivers, challenges, and opportunities, providing
Pentavalent Vaccine Market Future Scope, Industry Insight, Revenue Analysis and …
Pentavalent Vaccine Market revenue is expected to grow at a CAGR of 3.3% through 2023 to 2029, reaching nearly USD 3.21 Bn. Pentavalent Vaccine Market Report Scope and Research Methodology Forecasting the market until 2029 is based on real-time output, considering data from 2022 and estimations derived from key players' disclosures. The projections take into account actual numbers from 2018 to 2022, incorporating the impact of global lockdowns in 2020 and 2021